{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:30:07Z","timestamp":1767832207219,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00125-008-1125-6","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T08:44:29Z","timestamp":1219999469000},"page":"2078-2087","source":"Crossref","is-referenced-by-count":30,"title":["Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2"],"prefix":"10.1007","volume":"51","author":[{"given":"D.","family":"van Deursen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. M.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,30]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1368-5031.2005.00571.x","volume":"59","author":"GI Varughese","year":"2005","unstructured":"Varughese GI, Tomson J, Lip GY (2005) Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract 59:798\u2013816","journal-title":"Int J Clin Pract"},{"key":"1125_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.coph.2005.01.002","volume":"5","author":"BE Sobel","year":"2005","unstructured":"Sobel BE, Schneider DJ (2005) Cardiovascular complications in diabetes mellitus. Curr Opin Pharmacol 5:143\u2013148","journal-title":"Curr Opin Pharmacol"},{"key":"1125_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ecl.2004.12.001","volume":"34","author":"GM Reaven","year":"2005","unstructured":"Reaven GM (2005) Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am 34:49\u201362","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1125_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1210\/er.2005-0007","volume":"27","author":"J Nigro","year":"2006","unstructured":"Nigro J, Osman N, Dart AM, Little PJ (2006) Insulin resistance and atherosclerosis. Endocr Rev 27:242\u2013259","journal-title":"Endocr Rev"},{"key":"1125_CR5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.ATV.17.5.834","volume":"17","author":"SJ Bredie","year":"1997","unstructured":"Bredie SJ, Tack CJ, Smits P, Stalenhoef AF (1997) Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives. Arterioscler Thromb Vasc Biol 17:1465\u20131471","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 3","key":"1125_CR6","first-page":"C10","volume":"22","author":"JD Brunzell","year":"1999","unstructured":"Brunzell JD, Hokanson JE (1999) Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22(Suppl 3):C10\u2013C13","journal-title":"Diabetes Care"},{"key":"1125_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1210\/jc.2005-2084","volume":"91","author":"HN Ginsberg","year":"2006","unstructured":"Ginsberg HN (2006) Review: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 91:383\u2013392","journal-title":"J Clin Endocrinol Metab"},{"key":"1125_CR8","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1194\/jlr.R200008-JLR200","volume":"43","author":"H Jansen","year":"2002","unstructured":"Jansen H, Verhoeven AJM, Sijbrands EJG (2002) Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 43:1352\u20131362","journal-title":"J Lipid Res"},{"key":"1125_CR9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1194\/jlr.R200017-JLR200","volume":"44","author":"SS Deeb","year":"2003","unstructured":"Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD (2003) Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 44:1279\u20131286","journal-title":"J Lipid Res"},{"key":"1125_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","volume":"36","author":"S Rashid","year":"2003","unstructured":"Rashid S, Watanabe T, Sakaue T, Lewis GF (2003) Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem 36:421\u2013429","journal-title":"Clin Biochem"},{"key":"1125_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-2275(20)32058-7","volume":"41","author":"H Allayee","year":"2000","unstructured":"Allayee H, Dominguez KM, Aouizerat BE et al (2000) Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J. Lipid Res 41:245\u2013252","journal-title":"J. Lipid Res"},{"key":"1125_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9150(99)00077-5","volume":"145","author":"KCB Tan","year":"1999","unstructured":"Tan KCB, Shiu SWM, Chu BYM (1999) Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 145:273\u2013278","journal-title":"Atherosclerosis"},{"key":"1125_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2337\/diacare.26.2.427","volume":"26","author":"II Berk-Planken","year":"2003","unstructured":"Berk-Planken II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H (2003) Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. Diabetes Care 26:427\u2013432","journal-title":"Diabetes Care"},{"key":"1125_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2362.1992.tb01472.x","volume":"22","author":"C Baynes","year":"1992","unstructured":"Baynes C, Henderson AD, Richmond W, Johnston DG, Elkeles RS (1992) The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest 22:341\u2013346","journal-title":"Eur J Clin Invest"},{"key":"1125_CR15","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.ATV.17.11.2837","volume":"17","author":"H Jansen","year":"1997","unstructured":"Jansen H, Verhoeven AJM, Weeks L et al (1997) Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 17:2837\u20132842","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1125_CR16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/01.ATV.20.7.1789","volume":"20","author":"J Pihlajam\u00e4ki","year":"2000","unstructured":"Pihlajam\u00e4ki J, Karjalainen L, Karhap\u00e4\u00e4 P et al (2000) G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 20:1789\u20131795","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1125_CR17","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/diabetes.53.11.2893","volume":"53","author":"GF Lewis","year":"2004","unstructured":"Lewis GF, Murdoch S, Uffelman K et al (2004) Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone. Diabetes 53:2893\u20132900","journal-title":"Diabetes"},{"key":"1125_CR18","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/01.ATV.19.11.2701","volume":"19","author":"MC Carr","year":"1999","unstructured":"Carr MC, Hokanson JE, Deeb SS, Purnell JQ, Mitchell ES, Brunzell JD (1999) A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol 19:2701\u20132707","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1125_CR19","doi-asserted-by":"crossref","first-page":"S689","DOI":"10.1042\/bst025s689","volume":"25","author":"L Nimmo","year":"1997","unstructured":"Nimmo L, McColl AJ, Rosankiewicz JZ, Richmond W, Elkeles RS (1997) Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans 25:S689","journal-title":"Biochem Soc Trans"},{"key":"1125_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2004.10.027","volume":"179","author":"GJ Botma","year":"2005","unstructured":"Botma GJ, van Deursen D, Vieira D, van Hoek M, Jansen H, Verhoeven AJM (2005) Sterol-regulatory-element binding protein inhibits upstream stimulator factor-stimulated hepatic lipase gene expression. Atherosclerosis 179:61\u201367","journal-title":"Atherosclerosis"},{"key":"1125_CR21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/diabetes.50.8.1851","volume":"50","author":"AY Tu","year":"2001","unstructured":"Tu AY, Albers JJ (2001) Glucose regulates the transcription of human genes relevant to HDL metabolism. Diabetes 50:1851\u20131856","journal-title":"Diabetes"},{"key":"1125_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0021-9150(00)00478-0","volume":"154","author":"GJ Botma","year":"2001","unstructured":"Botma GJ, Verhoeven AJM, Jansen H (2001) Hepatic lipase promoter activity is reduced by the C-480G and G-216A substitutions present in the common LIPC variant and is increased by upstream stimulatory factor. Atherosclerosis 154:625\u2013632","journal-title":"Atherosclerosis"},{"key":"1125_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0749.2005.00262.x","volume":"18","author":"S Corre","year":"2005","unstructured":"Corre S, Galibert MD (2005) Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res 18:337\u2013348","journal-title":"Pigment Cell Res"},{"key":"1125_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj3330705","volume":"333","author":"PB Iynedjian","year":"1998","unstructured":"Iynedjian PB (1998) Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene. Biochem J 333:705\u2013712","journal-title":"Biochem J"},{"key":"1125_CR25","doi-asserted-by":"crossref","first-page":"26367","DOI":"10.1074\/jbc.272.42.26367","volume":"272","author":"D Wang","year":"1997","unstructured":"Wang D, Sul HS (1997) Upstream stimulatory factor binding to the E-box at \u201365 is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem 272:26367\u201326374","journal-title":"J Biol Chem"},{"key":"1125_CR26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/MCB.25.4.1537-1548.2005","volume":"25","author":"M Nowak","year":"2005","unstructured":"Nowak M, Helleboid-Chapman A, Jakel H et al (2005) Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol Cell Biol 25:1537\u20131548","journal-title":"Mol Cell Biol"},{"key":"1125_CR27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1074\/jbc.274.3.1216","volume":"274","author":"A Ribeiro","year":"1999","unstructured":"Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P (1999) Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem 274:1216\u20131255","journal-title":"J Biol Chem"},{"key":"1125_CR28","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1074\/jbc.M200227200","volume":"277","author":"D Pastier","year":"2002","unstructured":"Pastier D, Lacorte JM, Chambaz J, Cardot P, Ribeiro A (2002) Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4. J Biol Chem 277:15199\u201315206","journal-title":"J Biol Chem"},{"key":"1125_CR29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1042\/bj20021142","volume":"370","author":"E Salero","year":"2003","unstructured":"Salero E, Gimenez C, Zafra F (2003) Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene. Biochem J 370:979\u2013986","journal-title":"Biochem J"},{"key":"1125_CR30","doi-asserted-by":"crossref","first-page":"20175","DOI":"10.1074\/jbc.273.32.20175","volume":"273","author":"VS Vallet","year":"1998","unstructured":"Vallet VS, Casado M, Henrion AA et al (1998) Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J Biol Chem 273:20175\u201320179","journal-title":"J Biol Chem"},{"key":"1125_CR31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diabetes.51.2.293","volume":"51","author":"F Smih","year":"2002","unstructured":"Smih F, Rouet P, Lucas S et al (2002) Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose. Diabetes 51:293\u2013300","journal-title":"Diabetes"},{"key":"1125_CR32","doi-asserted-by":"crossref","first-page":"44485","DOI":"10.1074\/jbc.M206235200","volume":"277","author":"M Bidder","year":"2002","unstructured":"Bidder M, Shao JS, Charlton-Kachigian N, Loewy AP, Semenkovich CF, Towler DA (2002) Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J Biol Chem 277:44485\u201344496","journal-title":"J Biol Chem"},{"key":"1125_CR33","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1074\/jbc.M313524200","volume":"279","author":"C Weigert","year":"2004","unstructured":"Weigert C, Brodbeck K, Sawadogo M, H\u00e4ring HU, Schleicher ED (2004) Upstream stimulatory factor (USF) proteins induce human TGF-b1 gene activation via the glucose-response element \u20131013\/\u22121002 in mesangial cells. J Biol Chem 279:15908\u201315915","journal-title":"J Biol Chem"},{"key":"1125_CR34","doi-asserted-by":"crossref","first-page":"34311","DOI":"10.1074\/jbc.M401629200","volume":"279","author":"S Wang","year":"2004","unstructured":"Wang S, Skorczewiski J, Feng X, Mei L, Murphy-Ullrich JE (2004) Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-\u03b2 activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279:34311\u201334322","journal-title":"J Biol Chem"},{"key":"1125_CR35","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00125-005-1914-0","volume":"48","author":"MC Ng","year":"2005","unstructured":"Ng MC, Miyake K, So WY et al (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 48:2018\u20132024","journal-title":"Diabetologia"},{"key":"1125_CR36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","volume":"36","author":"P Pajukanta","year":"2004","unstructured":"Pajukanta P, Lilja HE, Sinsheimer JS et al (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36:371\u2013376","journal-title":"Nat Genet"},{"key":"1125_CR37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00439-005-1340-x","volume":"117","author":"H Coon","year":"2005","unstructured":"Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC (2005) Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet 117:444\u2013451","journal-title":"Hum Genet"},{"key":"1125_CR38","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.pgen.0020069","volume":"2","author":"K Komulainen","year":"2006","unstructured":"Komulainen K, Alanne M, Auro K et al (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PloS Genetics 2:e69","journal-title":"PloS Genetics"},{"key":"1125_CR39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molmed.2004.06.011","volume":"10","author":"CC Shoulders","year":"2004","unstructured":"Shoulders CC, Naoumova RP (2004) USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med 10:362\u2013365","journal-title":"Trends Mol Med"},{"key":"1125_CR40","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddi294","volume":"14","author":"J Naukkarinen","year":"2005","unstructured":"Naukkarinen J, Gentile M, Soro-Paavonen A et al (2005) USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 14:2595\u20132605","journal-title":"Hum Mol Genet"},{"key":"1125_CR41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/hmg\/ddh168","volume":"13","author":"W Putt","year":"2004","unstructured":"Putt W, Palmen J, Nicaud V et al (2004) Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 13:1587\u20131597","journal-title":"Hum Mol Genet"},{"key":"1125_CR42","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/jc.2005-0399","volume":"90","author":"J Hoffstedt","year":"2005","unstructured":"Hoffstedt J, Ryden M, Wahrenberg H, van Harmelen V, Arner P (2005) Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis. J Clin Endocrinol Metab 90:5356\u20135360","journal-title":"J Clin Endocrinol Metab"},{"key":"1125_CR43","doi-asserted-by":"crossref","unstructured":"van Deursen D, Botma GJ, Jansen H, Verhoeven AJM (2008) Down-regulation of hepatic lipase expression by elevation of cAMP in human hepatoma but not adrenocortical cells. Mol Cell Endocrinol doi: 10.1016\/j.mce.2008.07.004","DOI":"10.1016\/j.mce.2008.07.004"},{"key":"1125_CR44","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1128\/JVI.77.18.9852-9861.2003","volume":"77","author":"HR McMurray","year":"2003","unstructured":"McMurray HR, McCance DJ (2003) Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 77:9852\u20139861","journal-title":"J Virol"},{"key":"1125_CR45","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00125-007-0719-8","volume":"50","author":"S Linthout Van","year":"2007","unstructured":"Van Linthout S, Riad A, Dhayat N et al (2007) Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia 50:1977\u20131986","journal-title":"Diabetologia"},{"key":"1125_CR46","doi-asserted-by":"crossref","first-page":"28721","DOI":"10.1074\/jbc.M601576200","volume":"281","author":"L Ma","year":"2006","unstructured":"Ma L, Robinson LN, Towle HC (2006) ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 281:28721\u201328730","journal-title":"J Biol Chem"},{"key":"1125_CR47","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/bioinformatics\/bti473","volume":"21","author":"K Cartharius","year":"2005","unstructured":"Cartharius K, Frech K, Grote K et al (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933\u20132942","journal-title":"Bioinformatics"},{"key":"1125_CR48","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1074\/jbc.M107895200","volume":"277","author":"T Kawaguchi","year":"2002","unstructured":"Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K (2002) Mechanism for fatty acid \u201csparing\u201d effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277:3829\u20133835","journal-title":"J Biol Chem"},{"key":"1125_CR49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0005-2760(92)90305-F","volume":"1128","author":"H Jansen","year":"1992","unstructured":"Jansen H, van Tol A, Auwerx J, Skretting G, Staels B (1992) Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats. Biochim Biophys Acta 1128:181\u2013185","journal-title":"Biochim Biophys Acta"},{"key":"1125_CR50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-2007-1009136","volume":"21","author":"E Jensen","year":"1989","unstructured":"Jensen E, Hansson P, Floren CH, Nilsson A, Nilsson-Ehle P (1989) Cell-density-dependent release of hepatic lipase from cultured rat hepatocytes. Horm Metab Res 21:4\u20137","journal-title":"Horm Metab Res"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1125-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T18:40:38Z","timestamp":1631731238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-008-1125-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,30]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s00125-008-1125-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,30]]}}}